Sign up for the QMED & MD+DI Daily newsletter.
2015 MDEA Finalists: DuoResp Spiromax
DuoResp Spiromax DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates.
April 30, 2015
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "2015 MDEA Finalists: DuoResp Spiromax")
DuoResp Spiromax
DuoResp Spiromax, manufactured by Teva Pharmaceuticals Europe (UK) is a dry-powder inhaler for existing medicines for asthma and COPD that uses an intuitive design to minimize the training required for patients and provide consistent drug delivery across inspiratory flow rates. Supply/design credit: Gerresheimer |
|
You May Also Like
.svg?width=300&auto=webp&quality=80&disable=upscale)
